Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Calhoun

Showing results (91-100 of 188) with videos related to

Pageof 19
Sort By:
American Journal of Hypertension|March 18, 2020
Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept StudyMohammed Siddiqui, Hemal Bhatt, Eric K Judd, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2017
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is RelevantLama Ghazi, Suzanne Oparil, David A Calhoun, et al.
Journal of Hypertension|February 18, 2016
Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone statusLama Ghazi, Tanja Dudenbostel, Chee Paul Lin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 13, 2020
Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertensionAnping Cai, Mohammed Siddiqui, Eric K Judd, et al.
Current Medical Research and Opinion|June 1, 2013
Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertensionDavid A Calhoun, Yves Lacourcière, Nora Crikelair, et al.
Genetic Testing|September 4, 2004
Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosisBret L Hicken, David A Calhoun, James C Barton, et al.
Hypertension (Dallas, Tex. : 1979)|August 17, 2016
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant HypertensionTanja Dudenbostel, Lama Ghazi, Mingchun Liu, et al.
Hypertension (Dallas, Tex. : 1979)|December 25, 2018
Prevalence of Apparent Treatment-Resistant Hypertension in the United StatesRobert M Carey, Swati Sakhuja, David A Calhoun, et al.
Hypertension (Dallas, Tex. : 1979)|May 20, 2015
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment FailureTanja Dudenbostel, Maria C Acelajado, Roberto Pisoni, et al.
American Journal of Hypertension|December 13, 2016
Update From the Editors to Our ReadersErnesto L Schiffrin, David A Calhoun, John M Flack, et al.
Pageof 19

Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
American Journal of Hypertension|March 18, 2020
Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept StudyMohammed Siddiqui, Hemal Bhatt, Eric K Judd, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2017
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is RelevantLama Ghazi, Suzanne Oparil, David A Calhoun, et al.
Journal of Hypertension|February 18, 2016
Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone statusLama Ghazi, Tanja Dudenbostel, Chee Paul Lin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 13, 2020
Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertensionAnping Cai, Mohammed Siddiqui, Eric K Judd, et al.
Current Medical Research and Opinion|June 1, 2013
Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertensionDavid A Calhoun, Yves Lacourcière, Nora Crikelair, et al.
Genetic Testing|September 4, 2004
Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosisBret L Hicken, David A Calhoun, James C Barton, et al.
Hypertension (Dallas, Tex. : 1979)|August 17, 2016
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant HypertensionTanja Dudenbostel, Lama Ghazi, Mingchun Liu, et al.
Hypertension (Dallas, Tex. : 1979)|December 25, 2018
Prevalence of Apparent Treatment-Resistant Hypertension in the United StatesRobert M Carey, Swati Sakhuja, David A Calhoun, et al.
Hypertension (Dallas, Tex. : 1979)|May 20, 2015
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment FailureTanja Dudenbostel, Maria C Acelajado, Roberto Pisoni, et al.
American Journal of Hypertension|December 13, 2016
Update From the Editors to Our ReadersErnesto L Schiffrin, David A Calhoun, John M Flack, et al.
Pageof 19